Hyperliquid Strategies (NASDAQ:PURR – Get Free Report) had its target price hoisted by equities research analysts at Chardan Capital from $8.15 to $8.45 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Chardan Capital’s price objective suggests a potential upside of 86.12% from the company’s current price.
Hyperliquid Strategies Price Performance
Shares of PURR stock opened at $4.54 on Thursday. Hyperliquid Strategies has a 12-month low of $3.01 and a 12-month high of $5.78.
Hyperliquid Strategies (NASDAQ:PURR – Get Free Report) last announced its earnings results on Wednesday, February 11th. The company reported ($7.43) earnings per share for the quarter.
Hyperliquid Strategies Company Profile
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
Further Reading
- Five stocks we like better than Hyperliquid Strategies
- Is THIS the Next Big Money Rush?
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Hyperliquid Strategies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperliquid Strategies and related companies with MarketBeat.com's FREE daily email newsletter.
